A multiplex real-time PCR assay for the VitaPCR™ platform that simultaneously detects Influenza and SARS-CoV-2 from patient samples.
Manufactured by
Singapore, Singapore
Today, doctors face the delicate challenge of making accurate diagnoses daily. However, the tools currently available to them are far from perfect. Medical practitioners often find themselves having to compromise between performance and convenience. Since 2011, Credo Diagnostics has been researching and developing revolutionary diagnostic technologies. Our mission is to create, manufacture, and commercialize accurate, rapid, and affordable molecular diagnostic platforms that can be used at Point-of-Care. We understand the importance of simplifying processes and speeding up diagnostic turnaround times, all while keeping costs low and ensuring the highest level of accuracy. That s why we provide innovative solutions for diagnosis in the field of Human Health. As a diagnostic company, we believe we have a moral responsibility and duty to doctors and patients. We strive to provide effective and rapid Point-of-Care Molecular Diagnostics that will redefine healthcare and revolutionize human clinical management. Credo Diagnostics is committed to improving the tools available to doctors, enabling them to make more accurate diagnoses efficiently and affordably. We are dedicated to advancing healthcare through our innovative molecular diagnostic platforms, ultimately enhancing patient care and outcomes.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
KogeneBiotech Co., Ltd.
South Korea · 4 relevant products
Applied Biocode, Inc.
United States · 3 relevant products
APPOLON BIOTECK SAS
France · 2 relevant products
SeeGene Middle East FZE
South Korea · 2 relevant products
Hangzhou AllTest Biotech Co.,Ltd
China · 9 relevant products
Deaou Gene Technology Co.,Ltd
China · 2 relevant products
VITASSAY HEALTHCARE S.L.
Spain · 1 relevant product
HK UNI-MEDICA TECHNOLOGY CO.,LIMITED
China · 1 relevant product
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 3 relevant products
Coyote Bioscience Co.,Ltd
China · 4 relevant products
52 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 110 closest product alternatives
KogeneBiotech Co., Ltd. · South Korea
Multiplex real-time PCR assay enabling simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B from a single sample. This molecular diagnostic test provides efficient multi-pathogen screening in clinical settings.
Applied Biocode, Inc. · United States
A clinical diagnostic assay for simultaneous detection of SARS-CoV-2 and influenza pathogens. This multiplex testing product incorporates Applied Biocode's Barcoded Magnetic Bead (BMB) technology for comprehensive respiratory pathogen identification.
Applied Biocode, Inc. · United States
Multiplex molecular diagnostic assay for simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B. Enables comprehensive respiratory pathogen screening in single test format.
APPOLON BIOTECK SAS · France
Multiplex RT-PCR kit for detection of major respiratory viral infections including SARS-CoV-2, influenza, and respiratory syncytial virus. This test enables simultaneous identification of multiple clinically significant respiratory viruses.
SeeGene Middle East FZE · South Korea
A multiplex diagnostic assay for the simultaneous detection of SARS-CoV-2, Influenza A, Influenza B, and Respiratory Syncytial Virus. This assay is part of the Allplex™ product line for comprehensive respiratory infection testing.
Hangzhou AllTest Biotech Co.,Ltd · China
A real-time quantitative PCR assay for the detection and quantification of SARS-CoV-2 in human samples.
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for influenza virus detection with high sensitivity and specificity. Designed for rapid identification of influenza infections in clinical settings.
SeeGene Middle East FZE · South Korea
A diagnostic assay for the detection of SARS-CoV-2, the virus responsible for COVID-19. This assay is part of the Allplex™ product line for respiratory infection testing.
KogeneBiotech Co., Ltd. · South Korea
Real-time PCR molecular diagnostic test for detection of SARS-CoV-2 virus. This assay enables rapid identification of COVID-19 infection through quantitative PCR methodology. The test was among the first developed and supplied in Korea.
VITASSAY HEALTHCARE S.L. · Spain
Quantitative PCR assay technology providing automation for quantitative, accurate, and reproducible diagnostic results. Available in lyophilized format for enhanced stability and reliability in pathogen detection.
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for SARS-CoV-2 detection with high sensitivity and specificity. Delivers reliable results for COVID-19 diagnosis in clinical and point-of-care settings.
HK UNI-MEDICA TECHNOLOGY CO.,LIMITED · China
Multiplex real-time PCR assay for simultaneous detection of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus. Facilitates rapid differential diagnosis of respiratory viral infections.
98 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products